A quote needs the medicine’s name
The evidence cards
Bring the exact medicine name to the discussion. Ask whether the evidence covers that product and the health problem being treated.
Keep these questions together
For approval, the Food and Drug Administration (FDA) reviews a medicine for particular uses.
Semaglutide is the medicine name in Wegovy products.
As of September 26, 2026, the semaglutide (Wegovy) label included weight-management uses.
Ask which use fits the treatment being discussed and what the expected benefit would mean for you.
FDA guidance checked September 26, 2026, listed misleading claims about compounded medicines.
These included saying studies prove a compounded product gives the same result as an approved medicine.
Compounded describes a medicine prepared to meet an order. Ask for the evidence for the actual preparation on offer.
A finding about an approved product cannot be treated as proof of the same result from a custom preparation.
Registration means entering a facility or product in official records; it does not mean FDA reviewed and approved the medicine.
On September 26, 2026, FDA’s rules still kept that listing separate from drug approval.
A facility or product appearing in an official list did not mean FDA had approved it.
Ask: “Has FDA approved this exact medicine for the use being discussed?” A badge or a number in a list does not answer that question.
FDA explains that a report of harm alone cannot prove the medicine was its cause.
Those reports also cannot establish how often a problem occurs.
Ask what the source actually measured and which people and products it covered.